Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1α

• Ngā kaituhi matua: Jieru Han (Author), Wenhao Li (Author), Guangyu Shi (Author), Yunlei Huang (Author), Xutao Sun (Author), Na Sun (Author), Deyou Jiang (Author)
• Hōputu: Pukapuka
• I whakaputaina: Hindawi Limited, 2022-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Ulcerative colitis (UC) is a complex inflammatory bowel disease (IBD) associated with mitochondrial function. Atractylenolide III (AT III) is a natural product with anti-inflammatory effects. The aim of this work is to investigate the protective effect of AT III on UC and its underlying mechanisms....